Bernard Fongang, PhD is an Associate Professor of Bioinformatics at the Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases (UT Health San Antonio, USA). His research focuses on developing advanced computational tools to understand the genetic, genomic, and environmental factors involved in Alzheimer’s disease and other neurological disorders.

His work particularly explores the interaction between the gut microbiome, serotonin receptors, and multi-omics data (genomics, proteomics, and metabolomics), aiming to identify molecular mechanisms associated with the risk of dementia and cerebrovascular disease. He contributes to major international initiatives such as the Framingham Heart Study and the CHARGE Consortium, investigating genetic biomarkers, gene expression patterns, and novel therapeutic targets.

Through the development of innovative algorithms and integrative approaches, his research seeks to advance personalized medicine models for the prevention and treatment of cognitive decline, stroke, and dementia.